0000950170-25-050531 | 20-F | XBRL Viewer

aplm_GrantDateOptionFairValuePerShare

$ 9.33

aplm_GrantDateOptionFairValuePerShare

15.17

aplm_GrantDateOptionFairValuePerShare

Stock Issued During Period, Shares, Convesion of Preferred Stock into Ordinary Shares

aplm_GrantDateOptionFairValuePerShare

$ 51.1

IFRS 2 Listing Expense

aplm_Ifrs2ListingExpense

$ 45,524,000

IFRS 2 Listing Expense

aplm_Ifrs2ListingExpense

$ 45,524,000

aplm_StockIssuedDuringPeriodSharesConvesionOfPreferredStockIntoOrdinaryShares

544,210

Stock Shares Issued During The Period Exercise Of Stock Options Shares

aplm_StockSharesIssuedDuringThePeriodExerciseOfStockOptionsShares

85,521

Stock Shares Issued During The Period Exercise Of Stock Options Shares

aplm_StockSharesIssuedDuringThePeriodExerciseOfStockOptionsShares

6,130

Stock Shares Issued During The Period Exercise Of Stock Options Shares

aplm_StockSharesIssuedDuringThePeriodExerciseOfStockOptionsShares

624

Stock Shares Issued During The Period Exercise Of Stock Options Shares

aplm_StockSharesIssuedDuringThePeriodExerciseOfStockOptionsShares

468

Stock Issued During Period Value, Business Combination, Net of Redemptions

aplm_StockIssuedDuringPeriodValueBusinessCombinationNetOfRedemptions

$ 757,000

Stock Issued During Period Value, Business Combination, Net of Redemptions

aplm_StockIssuedDuringPeriodValueBusinessCombinationNetOfRedemptions

$ 757,000

aplm_ConvertedGrantDateOptionFairValuePerShare

$ 130.2

aplm_ConvertedGrantDateOptionFairValuePerShare

211.6

aplm_ConvertedGrantDateOptionFairValuePerShare

aplm_ConvertedGrantDateOptionFairValuePerShare

712.7

Stock Issued During Period Shares, Business Combination, Net of Redemptions

aplm_ConvertedGrantDateOptionFairValuePerShare

$ 60.42

aplm_StockIssuedDuringPeriodSharesBusinessCombinationNetOfRedemptions

33,127

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

$ 0

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

93,000

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

93,000

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

122,000

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

122,000

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

(81,000)

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Interest Expense Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughInterestExpenseLiabilitiesArisingFromFinancingActivities

$ (81,000)

Converted Exercise Price, Share Options Granted 2019

aplm_ConvertedExercisePriceShareOptionsGranted2019

$ 432

Converted Exercise Price, Share Options Granted 2019

aplm_ConvertedExercisePriceShareOptionsGranted2019

Converted Exercise Price, Share Options Granted 2019

aplm_ConvertedExercisePriceShareOptionsGranted2019

1,001

Converted Exercise Price, Share Options Granted 2019

aplm_ConvertedExercisePriceShareOptionsGranted2019

$ 77

aplm_LineOfCreditWithdrawnAmount

$ 20,000,000

aplm_LineOfCreditWithdrawnAmount

$ 2,800,000

aplm_LineOfCreditWithdrawnAmount

$ 10,000,000

aplm_LineOfCreditWithdrawnAmount

$ 1,400,000

aplm_RestrictedShareAwardsVestedValue

21,000

^[1]

aplm_RestrictedShareAwardsVestedValue

39,000

^[1]

aplm_RestrictedShareAwardsVestedValue

(39,000)

^[1]

aplm_RestrictedShareAwardsVestedValue

21,000

^[1]

aplm_RestrictedShareAwardsVestedValue

68,000

^[1]

aplm_RestrictedShareAwardsVestedValue

4,000

^[1]

aplm_RestrictedShareAwardsVestedValue

(4,000)

^[1]

Restricted Share Awards Vested Shares

aplm_RestrictedShareAwardsVestedValue

$ 68,000

^[1]

aplm_RestrictedShareAwardsVestedShares

835

^[1]

Restricted Share Awards Vested Shares

aplm_RestrictedShareAwardsVestedShares

4,967

^[1]

Additional Withdrawn Amount

aplm_AdditionalWithdrawnAmount

$ 5,000,000

Additional Withdrawn Amount

aplm_AdditionalWithdrawnAmount

$ 700,000

Allocated Share Based Compensation Consulting Fees

aplm_AllocatedShareBasedCompensationConsultingFees

27,000

Allocated Share Based Compensation Consulting Fees

aplm_AllocatedShareBasedCompensationConsultingFees

19,000

Allocated Share Based Compensation Consulting Fees

aplm_AllocatedShareBasedCompensationConsultingFees

$ 56,000

Disclosure of number and weighted average exercise prices of other equity instruments of Restricted stock [text block]

aplm_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsOfRestrictedStockTextBlock

There was no restricted stock issued under the 2016 Plan during the years ended December 31, 2023 and 2024. Under the 2023 Plan, the following table discloses movements of the Company’s restricted stock under the 2023 Plan for the year December 31, 2024.


	Year ended December 31, 2024
	Number of restricted stocks			Weighted- average exercise price
Outstanding at January 1, 2024		2,080		$	541.00
Restricted stock granted		21,704			81.82
Restricted stock vested		(22,399	)		96.07
Restricted stock forfeited		(277	)		541.00
Outstanding at December 31, 2024		1,108		$	541.00
Exercisable at the end of the year		—

Stock Issued Through Exercise of Stock Options Shares

aplm_StockIssuedThroughExerciseOfStockOptionsShares

6,130

^[2]

Stock Issued Through Exercise of Stock Options Shares

aplm_StockIssuedThroughExerciseOfStockOptionsShares

624

^[3]

Stock Issued Through Exercise of Stock Options Shares

aplm_StockIssuedThroughExerciseOfStockOptionsShares

468

Stock Issued Through Exercise of Stock Options Shares

aplm_StockIssuedThroughExerciseOfStockOptionsShares

150

aplm_ForfeitureOfVestedShareOptionsEquityValue

$ (1,646,000)

aplm_ForfeitureOfVestedShareOptionsEquityValue

1,646,000

aplm_ForfeitureOfVestedShareOptionsEquityValue

(198,000)

Value Of Shares Authorized

aplm_ForfeitureOfVestedShareOptionsEquityValue

$ 198,000

aplm_ValueOfSharesAuthorized

Value Of Shares Authorized

aplm_ValueOfSharesAuthorized

Value Of Shares Authorized

aplm_ValueOfSharesAuthorized

1,300

aplm_TimeDepositsInterestRate

0.00%

aplm_TimeDepositsInterestRate

0.00%

aplm_TimeDepositsInterestRate

5.10%

Disclousre of Detailed Information About Financial Assets and Financial Liabilities that are Measured at Fair Value on a Recurring Basis Explanatory [Text Block]

aplm_TimeDepositsInterestRate

5.10%

aplm_DisclousreOfDetailedInformationAboutFinancialAssetsAndFinancialLiabilitiesThatAreMeasuredAtFairValueOnARecurringBasisExplanatoryTextBlock

Fair value of the Group's financial assets and financial liabilities that are measured at fair value on a recurring basis.

Some of the Group's financial assets and financial liabilities are measured at fair value at the end of each reporting period. The following table gives information about how the fair values of these financial assets and financial liabilities are determined (in particular, the valuation techniques and inputs used).

         
        Fair value as of

         
        December 31, 2024

        December 31, 2023

        Fair
value
hierarchy

        Valuation technique(s)
and key inputs

        Significant
unobservable inputs

        Relationship of
unobservable inputs
to fair value

        Financial assets

Money market fund

—

5,761

Level 1

Redemption value quoted by banks with reference to the expected return of the underlying assets

N/A

N/A

        Financial liabilities

Maxpro public warrants
   assumed by
   Apollomics (Note 5)

95

259

Level 1

The public warrants are traded on the Nasdaq, the valuation is based on unadjusted quoted prices in active markets for identical assets or liabilities

N/A

N/A

Maxpro private warrants
   assumed by
   Apollomics, and
   Private warrants issued
   in connection with
   the conversion of the
   promissory note
   payable to the Maxpro
   Sponsor (Note 5)

6

15

Level 2

Private warrants are considered to be economically equivalent to the public warrants. As such, the valuation of the public warrants was used to value the private warrants

N/A

N/A

Penny warrants (Note 5)

1

56

Level 3

Black-Scholes model - the key inputs are: underlying share price, expected life in years, risk-free rate, expected volatility, and exercise price

N/A

N/A

Total warrant liabilities:

102

330

(i)

Fair value of the Group’s financial assets and financial liabilities that are measured at fair value on a recurring basis

Some of the Group’s financial assets and financial liabilities are measured at fair value at the end of each reporting period. The following table gives information about how the fair values of these financial assets and financial liabilities are determined (in particular, the valuation techniques and inputs used).

         
        Relationship of

         
        Fair value as of

        Significant

        unobservable

         
        December 31,

        Fair value

        Valuation technique(s) and key

        unobservable

        inputs to fair

         
        2023

        2024

        hierarchy

        inputs

        inputs

        value

        Financial assets

Money market fund

5,761

—

Level 1

Redemption value quoted by banks with reference to the expected return of the underlying assets

N/A

N/A

        Financial liabilities

Warrants

330

102

Level 1

Public warrants and private warrants are based on the valuation of the public price of APLMW which is directly observable market (level 1) while the penny warrants are based on the underlying share price of APLM, also a directly observable market (level 1)

N/A

N/A

Adjustments for Increase Decrease in Deposits Prepayments and Deferred Expenses

aplm_AdjustmentsForIncreaseDecreaseInDepositsPrepaymentsAndDeferredExpenses

$ 3,651,000

Adjustments for Increase Decrease in Deposits Prepayments and Deferred Expenses

aplm_AdjustmentsForIncreaseDecreaseInDepositsPrepaymentsAndDeferredExpenses

(932,000)

Adjustments for Increase Decrease in Deposits Prepayments and Deferred Expenses

aplm_AdjustmentsForIncreaseDecreaseInDepositsPrepaymentsAndDeferredExpenses

1,608,000

Adjustments for Increase Decrease in Deposits Prepayments and Deferred Expenses

aplm_AdjustmentsForIncreaseDecreaseInDepositsPrepaymentsAndDeferredExpenses

2,812,000

Adjustments for Increase Decrease in Deposits Prepayments and Deferred Expenses

aplm_AdjustmentsForIncreaseDecreaseInDepositsPrepaymentsAndDeferredExpenses

(630,000)

Adjustments for Increase Decrease in Deposits Prepayments and Deferred Expenses

aplm_AdjustmentsForIncreaseDecreaseInDepositsPrepaymentsAndDeferredExpenses

$ 316,000

Disclosure of Lease Liabilities Explanatory [Text Block]

aplm_DisclosureOfLeaseLiabilitiesExplanatoryTextBlock

23.

LEASE LIABILITIES


	As of December 31,
	2023			2024
Lease liabilities payable:
Within one year	$	158		$	233
More than one year, but not exceeding two years		126			484
More than two years, but not exceeding five years		141			249
		425			966
Less: Amount due for settlement within 12 months shown under current liabilities		(158	)		(233	)
Amount due for settlement after 12 months shown under non-current liabilities	$	267		$	733

The Group leased various offices, and plant and equipment as disclosed in Note 16 for its administration, and research and development activities. These lease liabilities were measured at the present value of the lease payments that are not yet paid.

The Group does not face a significant liquidity risk with regard to its lease liabilities.

The lease agreements did not contain any contingent rent nor any purchase option for the leases.

The weighted average incremental borrowing rates applied to lease liabilities range from 4.75% to 6.65% during the years ended December 31, 2023 and 2024.

Disclosure Of Detailed Information About Contractual Maturities Of Lease Liabilities Explanatory

aplm_DisclosureOfDetailedInformationAboutContractualMaturitiesOfLeaseLiabilitiesExplanatory


	As of December 31,
	2023			2024
Lease liabilities payable:
Within one year	$	158		$	233
More than one year, but not exceeding two years		126			484
More than two years, but not exceeding five years		141			249
		425			966
Less: Amount due for settlement within 12 months shown under current liabilities		(158	)		(233	)
Amount due for settlement after 12 months shown under non-current liabilities	$	267		$	733

Deficit In Subsidiaries

aplm_DeficitInSubsidiaries

$ 38,653,000

Deficit In Subsidiaries

aplm_DeficitInSubsidiaries

$ 8,132,000

Disclosure Of Detailed Information About Assets And Liabilities Denominated In Foreign Currencies Explanatory [Text Block]

aplm_DisclosureOfDetailedInformationAboutAssetsAndLiabilitiesDenominatedInForeignCurrenciesExplanatoryTextBlock

The carrying amounts of the Group’s foreign currency denominated monetary assets and monetary liabilities at the end of each reporting period are as follows:


	Assets				Liabilities
	As of December 31,				As of December 31,
	2023		2024		2023		2024
Renminbi (“RMB”)	$	6,071	$	3,069	$	5,443	$	1,286
Australian Dollars (“AUD”)		796		1,257		771		949
	$	6,867	$	4,326	$	6,214	$	2,235

Adjustments for Portion of PIPE issuance costs allocated to PIPE warrants

aplm_AdjustmentsForPortionOfPipeIssuanceCostsAllocatedToPipeWarrants

$ 38,000

aplm_Reserves

26,716,000

aplm_Reserves

39,148,000

aplm_Reserves

26,716,000

Adjustments For Fair Value Change of Convertible Preferred Shares

aplm_Reserves

39,148,000

aplm_AdjustmentsForFairValueChangeOfConvertiblePreferredShares

189,646,000

Adjustments For Fair Value Change of Convertible Preferred Shares

aplm_AdjustmentsForFairValueChangeOfConvertiblePreferredShares

$ 76,430,000

Number of warrants entitled for each share purchased

aplm_NumberOfWarrantsEntitledForEachSharePurchased

57,500

Adjustments for IFRS Two Listing Expense

aplm_AdjustmentsForIfrsTwoListingExpense

$ 45,524,000

Adjustments for IFRS Two Listing Expense

aplm_AdjustmentsForIfrsTwoListingExpense

$ 45,524,000

Business Combination Net Of Redemptions

aplm_BusinessCombinationNetOfRedemptions

33,127

Conversion Of pre Closing Apollomics Convertible Preferred Shares Into Post Closing Apollomics Ordinary Shares

aplm_ConversionOfPreClosingApollomicsConvertiblePreferredSharesIntoPostClosingApollomicsOrdinaryShares

544,210

Adjustments For Fair Value Gains Losses Of Financial assets

aplm_AdjustmentsForFairValueGainsLossesOfFinancialAssets

$ (323,000)

Adjustments For Fair Value Gains Losses Of Financial assets

aplm_AdjustmentsForFairValueGainsLossesOfFinancialAssets

(821,000)

Adjustments For Fair Value Gains Losses Of Financial assets

aplm_AdjustmentsForFairValueGainsLossesOfFinancialAssets

$ (222,000)

Percentage of Decrease in Foreign Exchange Rate

aplm_PercentageOfDecreaseInForeignExchangeRate

5.00%

Value Of Conversion Of pre Closing Apollomics Convertible Preferred Shares Into Post Closing Apollomics Ordinary Shares

aplm_ValueOfConversionOfPreClosingApollomicsConvertiblePreferredSharesIntoPostClosingApollomicsOrdinaryShares

$ 6

Percentage of Decrease Increase in Foreign Exchange Rate

aplm_PercentageOfDecreaseIncreaseInForeignExchangeRate

5.00%

Percentage of Increase in Foreign Exchange Rate

aplm_PercentageOfIncreaseInForeignExchangeRate

5.00%

Post Losing Apollomics Class B Ordinary Shares Issued To PIPE Investors Net Of Transaction Costs

aplm_PostLosingApollomicsClassBOrdinarySharesIssuedToPipeInvestorsNetOfTransactionCosts

2,300

Disclosure Of Detailed Information About Sensitivity Analysis of Foreign Exchange Rate Explanatory [Text Block]

aplm_DisclosureOfDetailedInformationAboutSensitivityAnalysisOfForeignExchangeRateExplanatoryTextBlock


	2022			2023		2024
Impact of RMB on loss for the year	$	386		$	659	$	1,872
Impact of AUD on loss for the year		(7	)		26		323

Issuance Of Post Closing Apollomics Class A Ordinary Shares Upon The Conversion Of post Closing Apollomics Series A Preferred Shares

aplm_IssuanceOfPostClosingApollomicsClassAOrdinarySharesUponTheConversionOfPostClosingApollomicsSeriesAPreferredShares

26,688

Description of Type of Measurement of Expected Credit Losses Financial assets at amortized cost

aplm_DescriptionOfTypeOfMeasurementOfExpectedCreditLossesFinancialAssetsAtAmortizedCost

12-month ECL

Description of Type of Measurement of Expected Credit Losses Financial assets at amortized cost

aplm_DescriptionOfTypeOfMeasurementOfExpectedCreditLossesFinancialAssetsAtAmortizedCost

12-month ECL

Description of Type of Measurement of Expected Credit Losses Financial assets at amortized cost

aplm_DescriptionOfTypeOfMeasurementOfExpectedCreditLossesFinancialAssetsAtAmortizedCost

Lifetime ECL- not credit-impaired

Description of Type of Measurement of Expected Credit Losses Financial assets at amortized cost

aplm_DescriptionOfTypeOfMeasurementOfExpectedCreditLossesFinancialAssetsAtAmortizedCost

Lifetime ECL- credit-impaired

Description of Type of Measurement of Expected Credit Losses Financial assets at amortized cost

aplm_DescriptionOfTypeOfMeasurementOfExpectedCreditLossesFinancialAssetsAtAmortizedCost

Amount is written off

aplm_DescriptionOfInternalCreditRatingProcess

The counterparty has a low risk of default and does not have any past-due amounts

aplm_DescriptionOfInternalCreditRatingProcess

Debtor frequently repays after due dates but settles the amounts in full

aplm_DescriptionOfInternalCreditRatingProcess

There have been significant increases in credit risk since initial recognition through information developed internally or external resources

aplm_DescriptionOfInternalCreditRatingProcess

There is evidence indicating the asset is credit-impaired

Adjustments for Fair Value Change of Financial Liabilities at FVTPL

aplm_DescriptionOfInternalCreditRatingProcess

There is evidence indicating that the debtor is in severe financial difficulty and the Group has no realistic prospect of recovery

aplm_AdjustmentsForFairValueChangeOfFinancialLiabilitiesAtFvtpl

$ (1,597,000)

Adjustments for Fair Value Change of Financial Liabilities at FVTPL

aplm_AdjustmentsForFairValueChangeOfFinancialLiabilitiesAtFvtpl

(222,000)

Adjustments for Fair Value Change of Financial Liabilities at FVTPL

aplm_AdjustmentsForFairValueChangeOfFinancialLiabilitiesAtFvtpl

$ (1,597,000)

Number of Shares Redeemed

aplm_NumberOfSharesRedeemed

102,701

Disclosure Of Internal Credit Exposure Explanatory [table text block]

aplm_DisclosureOfInternalCreditExposureExplanatoryTableTextBlock

The Group’s internal credit risk grading assessment comprises the following categories:


Internal credit rating	Description	Financial assets at amortized cost
Low risk	The counterparty has a low risk of default and does not have any past-due amounts	12-month ECL
Watch list	Debtor frequently repays after due dates but settles the amounts in full	12-month ECL
Doubtful	There have been significant increases in credit risk since initial recognition through information developed internally or external resources	Lifetime ECL - not credit-impaired
Loss	There is evidence indicating the asset is credit-impaired	Lifetime ECL - credit-impaired
Write-off	There is evidence indicating that the debtor is in severe financial difficulty and the Group has no realistic prospect of recovery	Amount is written off

Debt Conversion, Converted Instruments, Shares Issued

aplm_DebtConversionConvertedInstrumentsSharesIssued

1,553

Derecognition Of Right Of Use Assets Accumulated Depreciation Upon End Of Lease Term

aplm_DerecognitionOfRightOfUseAssetsAccumulatedDepreciationUponEndOfLeaseTerm

$ 296,000

Derecognition Of Right Of Use Assets Accumulated Depreciation Upon End Of Lease Term

aplm_DerecognitionOfRightOfUseAssetsAccumulatedDepreciationUponEndOfLeaseTerm

50,000

Derecognition Of Right Of Use Assets Accumulated Depreciation Upon End Of Lease Term

aplm_DerecognitionOfRightOfUseAssetsAccumulatedDepreciationUponEndOfLeaseTerm

346,000

Derecognition Of Right Of Use Assets Accumulated Depreciation Upon End Of Lease Term

aplm_DerecognitionOfRightOfUseAssetsAccumulatedDepreciationUponEndOfLeaseTerm

2,226,000

Derecognition Of Right Of Use Assets Accumulated Depreciation Upon End Of Lease Term

aplm_DerecognitionOfRightOfUseAssetsAccumulatedDepreciationUponEndOfLeaseTerm

28,000

Derecognition Of Right Of Use Assets Accumulated Depreciation Upon End Of Lease Term

aplm_DerecognitionOfRightOfUseAssetsAccumulatedDepreciationUponEndOfLeaseTerm

$ 2,254,000

aplm_DateOfIncorporation

Jan. 14, 2016

aplm_DateOfIncorporation

Nov. 04, 2016

aplm_DateOfIncorporation

Jun. 24, 2019

aplm_DateOfIncorporation

May 29, 2018

aplm_DateOfIncorporation

May 29, 2020

Shares Issued To PIPE Investors, Net Of Transaction Costs Shares

aplm_DateOfIncorporation

Aug. 19, 2022

aplm_SharesIssuedToPipeInvestorsNetOfTransactionCostsShares

191,667

Shares Issued To PIPE Investors, Net Of Transaction Costs Shares

aplm_SharesIssuedToPipeInvestorsNetOfTransactionCostsShares

191,667

Borrowings Principal Amount

aplm_BorrowingsPrincipalAmount

$ 1,500,000

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

(644,000)

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

(644,000)

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

Increase (Decrease) Through Issue Costs Accrued Liabilities Arising From Financing Activities

aplm_IncreaseDecreaseThroughIssueCostsAccruedLiabilitiesArisingFromFinancingActivities

Shares Issued To PIPE Investors, Net Of Transaction Costs

aplm_SharesIssuedToPipeInvestorsNetOfTransactionCosts

2,000

Shares Issued To PIPE Investors, Net Of Transaction Costs

aplm_SharesIssuedToPipeInvestorsNetOfTransactionCosts

5,047,000

Shares Issued To PIPE Investors, Net Of Transaction Costs

aplm_SharesIssuedToPipeInvestorsNetOfTransactionCosts

5,049,000

Shares Issued To PIPE Investors, Net Of Transaction Costs

aplm_SharesIssuedToPipeInvestorsNetOfTransactionCosts

$ 2

Shares Issued To Employees For Compensation Shares

aplm_SharesIssuedToEmployeesForCompensationShares

14,913

Shares Issued To Employees For Compensation Shares

aplm_SharesIssuedToEmployeesForCompensationShares

14,913

Adjustments for Realized Foreign Exchange Losses Gains

aplm_AdjustmentsForRealizedForeignExchangeLossesGains

$ 663,000

Adjustments for Realized Foreign Exchange Losses Gains

aplm_AdjustmentsForRealizedForeignExchangeLossesGains

$ (21,000)

Percentage of Redemption of Shares in Connection with Public Shares Available

aplm_PercentageOfRedemptionOfSharesInConnectionWithPublicSharesAvailable

99.20%

Shares Issued To Board Members For Board Fees Shares

aplm_SharesIssuedToBoardMembersForBoardFeesShares

693

Shares Issued To Board Members For Board Fees Shares

aplm_SharesIssuedToBoardMembersForBoardFeesShares

693

Adjustments For Fair Value Change Of Preferred Shares

aplm_AdjustmentsForFairValueChangeOfPreferredShares

$ 189,646,000

Adjustments For Fair Value Change Of Preferred Shares

aplm_AdjustmentsForFairValueChangeOfPreferredShares

$ 76,430,000

Number of Shares Issued and Fully Paid Exchange Ratio Pursuant to Business Combination

aplm_NumberOfSharesIssuedAndFullyPaidExchangeRatioPursuantToBusinessCombination

0.071679

Disclosure Of Detailed Information About Unrecognized Tax Losses Explanatory [Table Text Block]

aplm_DisclosureOfDetailedInformationAboutUnrecognizedTaxLossesExplanatoryTableTextBlock

The major deferred tax assets (liabilities) recognized and movements thereon during the years ended December 31, 2022, 2023 and 2024 are as follows:


	Accelerated tax depreciation			Accrual			Total
As of January 1, 2022		(32	)		32		$	—
Credit (charge) to profit or loss (Note 11)		(19	)		19			—
As of December 31, 2022		(51	)		51			—
Credit (charge) to profit or loss (Note 11)		40			(40	)		—
As of December 31, 2023		(11	)		11			—
Credit (charge) to profit or loss (Note 11)		6			(6	)		—
As of December 31, 2024	$	(5	)	$	5		$	—

Issuance Costs

aplm_IssuanceCosts

$ 38,000

Stock Issued During The Period Exercise Of Stock Options Shares

aplm_StockIssuedDuringThePeriodExerciseOfStockOptionsShares

85,521

Stock Issued During The Period Exercise Of Stock Options Shares

aplm_StockIssuedDuringThePeriodExerciseOfStockOptionsShares

6,130

Stock Issued During The Period Exercise Of Stock Options Shares

aplm_StockIssuedDuringThePeriodExerciseOfStockOptionsShares

624

Stock Issued During The Period Exercise Of Stock Options Shares

aplm_StockIssuedDuringThePeriodExerciseOfStockOptionsShares

Disclosure of Common Stock Outstanding of Business Combination [text block]

aplm_DisclosureOfCommonStockOutstandingOfBusinessCombinationTextBlock

The following table presents the total Apollomics ordinary shares outstanding immediately after the closing of the Business Combination:


	Number of Shares
Exchange of Maxpro Class A Common Stock for post-closing Apollomics Class A Ordinary Shares		4,900
Exchange of Maxpro Class B Common Stock for post-closing Apollomics Class A Ordinary Shares		25,875
Exchange of Maxpro Class A Common Stock subject to possible redemption that was not redeemed for post-closing Apollomics Class A Ordinary Shares		799
Issuance of post-closing Apollomics Class A Ordinary Shares to Maxpro Sponsor in connection with conversion of a convertible promissory note		1,553
Subtotal - Business Combination, net of redemptions		33,127
Issuance of post-closing Apollomics Class B Ordinary Shares to PIPE Investors		2,300
Conversion of pre-closing Apollomics convertible preferred shares (converted into pre-closing Apollomics Ordinary Shares prior to the Business Combination) into Post-Closing Apollomics Ordinary Shares		544,210
Issuance of Post-Closing Apollomics Ordinary Shares in connection with the Business Combination due to exercise of pre-closing Apollomics share options prior to the Business Combination		312
Total - Post-Closing Apollomics Ordinary Shares outstanding as a result of Business Combination, PIPE Financing, conversion of pre-closing Apollomics convertible preferred shares into Post-Closing Apollomics Ordinary Shares, and issuance of shares upon Closing due to pre-Closing exercise of share options (note i)		579,949

Note i: In addition to the 579,949 shares specified above, the following shares were included in the total 895,051 Post- Closing Apollomics Ordinary Shares outstanding as of December 31, 2023 on the consolidated statement of changes in stockholders' deficit: 1) 288,009 Post-Closing Apollomics Ordinary Shares were outstanding as a result of the exchange of all Pre-Closing Apollomics Ordinary Shares outstanding as of December 31, 2022 at the Exchange Ratio 2) 26,688 Post-Closing Apollomics Ordinary Shares were outstanding as a result of the conversion of Post-Closing Apollomics Series A Preferred Shares into Post-Closing Apollomics Class A Ordinary Shares in May 2023 at a conversion ratio of 1 to 1.25 3) 162 Post-Closing Apollomics Ordinary Shares were outstanding as a result of the exercise of share options in April 2023, and 150 Ordinary Shares as a result of the exercise of share options in November 2023.

aplm_OtherPayablesUndiscountedCashFlows

$ 5,970,000

aplm_OtherPayablesUndiscountedCashFlows

5,970,000

aplm_OtherPayablesUndiscountedCashFlows

10,768,000